Proprietary Hot Melt Extrusion & HME Services for Better Drug Delivery
This advanced technique, often delivered through HME services, helps drug developers overcome formulation issues. It enhances solubility, stability, and release profiles without adding unnecessary complexity.
At AbbVie Contract Manufacturing, hot melt extrusion isn’t just a tool—it’s a strategic advantage.
What Is Hot Melt Extrusion?
Hot melt extrusion (HME) is a process that uses heat and pressure to mix active pharmaceutical ingredients (APIs) with polymers. This forms a uniform, stable material that can be shaped into tablets, films, or granules.
Why use it?
-
Improves drug solubility and absorption
-
Eliminates the need for solvents
-
Offers controlled and sustained release
-
Increases product stability and shelf life
And with proprietary hot melt extrusion methods, the process becomes even more precise.
Why Proprietary HME Services Matter?
Hot melt extrusion has been around for decades. But not all HME processes are created equal.
Proprietary HME services like AbbVie’s bring added value through:
-
Optimized formulations
-
Scalable production platforms
-
Regulatory-compliant systems
-
Deep technical expertise
These enhancements reduce trial-and-error and get your product market-ready faster.
How AbbVie Delivers High-Performance HME Services
AbbVie has built a global reputation for excellence in pharmaceutical manufacturing. Their HME services are backed by decades of research and continuous innovation.
Here’s what you get:
-
Custom Formulation Design
Tailored HME systems to address solubility and permeability challenges. -
End-to-End Capabilities
From pre-formulation to commercial manufacturing—everything happens in one integrated workflow. -
State-of-the-Art Equipment
AbbVie uses twin-screw extruders, downstream pelletizers, and precision feeders for quality control. -
Global Regulatory Expertise
Support for regulatory filings in all major markets.
👉 Explore AbbVie’s full HME services here
When Should You Use Hot Melt Extrusion?
Not every drug needs HME. But for compounds with solubility or stability issues, it's often the best choice.
Consider HME if your drug:
-
Has low water solubility
-
Degrades easily under certain conditions
-
Requires targeted release (e.g., slow, extended, or pulsatile)
-
Needs taste-masking for oral delivery
-
Must avoid solvents in processing
In each of these cases, proprietary hot melt extrusion offers a clear edge.
Applications Across the Pharma Pipeline
AbbVie supports pharmaceutical and biotech companies at every stage:
-
Early R&D: Screening for polymer compatibility
-
Clinical Trials: Producing GMP-compliant clinical batches
-
Scale-Up: Moving from pilot to full-scale production
-
Commercial Launch: Reliable, global supply chain integration
Whether you’re working on a new chemical entity (NCE) or reformulating an existing drug, HME can unlock better outcomes.
CTA: Strengthen Your Drug’s Performance with HME
Formulation challenges don’t have to slow you down.
With AbbVie’s proprietary hot melt extrusion and HME services, you get the tools, talent, and tech to solve complex drug delivery problems—at any scale.
👉 Learn more and connect with our team
Deliver your next breakthrough with confidence.

Comments
Post a Comment